China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 94,100 shares, a growth of 129.0% from the January 15th total of 41,100 shares. Approximately 2.7% of the shares of the company are sold short. Based on an average daily volume of 1,030,000 shares, the short-interest ratio is currently 0.1 days.

China SXT Pharmaceuticals Price Performance

Shares of NASDAQ:SXTC traded down $0.01 during trading on Thursday, hitting $0.38. The company’s stock had a trading volume of 47,038 shares, compared to its average volume of 442,839. The company has a 50-day moving average of $0.42 and a 200-day moving average of $0.58. China SXT Pharmaceuticals has a 12 month low of $0.30 and a 12 month high of $3.37.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.